Pricing Log in Create free account

Curanex Pharmaceuticals Inc (CURX) vs NKGen Biotech, Inc. (NKGN)

Curanex Pharmaceuticals Inc and NKGen Biotech, Inc. are both Biotechnology companies. Curanex Pharmaceuticals Inc and NKGen Biotech, Inc. are of similar size ($9.1M and $8.8M). Across the 9 metrics below, NKGen Biotech, Inc. leads on 6 and Curanex Pharmaceuticals Inc on 3.

Valuation

Metric CURX NKGN Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 1.84 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (125.60%) (10,600.00%) (32.88%)
Free cash flow yield (137.14%) (4,296.38%) (23.13%)

Profitability

Metric CURX NKGN Biotechnology median
Gross margin — — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (411.10%) 44.70% (51.96%)
Return on assets (357.22%) (146.49%) (46.06%)
Return on invested capital (356.67%) 0.00% 0.00%

Growth

Metric CURX NKGN Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (523.51%) 71.38% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric CURX NKGN Biotechnology median
Debt to equity 0.00 (0.59) 0.00
Current ratio 45.95 0.05 4.97
Net debt to EBITDA 1.20 (1.69) 1.01

Dividend

Metric CURX NKGN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CURX NKGN Biotechnology median
Market cap 9.07m 8.76m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack